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Abstract
Vascular smooth muscle cells (VSMCs) are the predominant cell type in the blood vessel wall and normally adopt a quiescent, 
contractile phenotype. VSMC migration is tightly controlled, however, disease associated changes in the soluble and insoluble 
environment promote VSMC migration. Classically, studies investigating VSMC migration have described the influence of 
soluble factors. Emerging data has highlighted the importance of insoluble factors, including extracellular matrix stiffness 
and porosity. In this review, we will recap on the important signalling pathways that regulate VSMC migration and reflect 
on the potential importance of emerging regulators of VSMC function.
Keywords Vascular smooth muscle cell · Migration · Signalling · Mechanotransduction
Introduction
Cell migration begins at the earliest stages of life and it 
continuous as a fundamental process for survival (Vicente-
Manzanares et al. 2005). Smooth muscle cells are found 
in the hollow organs of the vascular, reproductive, urinary 
and digestive systems. In the vascular system, the vascu-
lar smooth muscle cells (VSMCs) are located in the tunica 
media between the loose connective tissue of the tunica 
adventitia and the endothelial layer of the tunica intima 
(Ahmed and Warren 2018). VSMC migration occurs dur-
ing several important physiological and pathological pro-
cesses ranging from early remodelling, response to injury, 
vascular disease (Tahir et al. 2015; Cai et al. 2015). VSMC 
migration is activated in response to multiple environmental 
cues including chemotactic, haptotatic and durotactic sig-
nals (Isenberg et al. 2009; Hartman et al. 2016; Kerr et al. 
2013). Promigratory stimuli activate signal transduction cas-
cades that trigger remodelling of the actin cytoskeleton and 
cell–extracellular matrix (ECM) adhesions that increase the 
migration capacity of VSMCs (Gerthoffer 2007). Similarly 
to other cell types, VSMC directional migration is initiated 
by external signals that stimulate receptors on the cell sur-
face, activating multiple signalling cascades that alter the 
cytoskeletal structure of the cell (Gerthoffer 2007). Typi-
cally, stimulation is initiated via G protein coupled recep-
tors (GPCRs) and receptor tyrosine kinases (RTKs), which 
in turn activate several downstream signalling pathways 
(Scherberich et al. 2000). Migration is a cyclical process, 
with external signalling inducing polarisation and filopodial 
projections, followed by lamellipodia extending from the 
cell (Louis and Zahradka 2010). This forms the leading edge 
of the cell. Nascent adhesions form, serving as anchor points 
for the newly formed protrusion to its ECM (Fig. 1). These 
adhesions associate with filamentous actin and actomyosin 
activity pulls the cell body forward (Fig. 1). Adhesions also 
serve as signalling conduits, allowing “inside-out” signalling 
by emitting the traction force generated by the cell (Ross 
et al. 2013). The force generated causes “outside-in” sig-
nalling to occur which further regulates the dynamics and 
maturation of the focal adhesions (Wrighton 2013). At the 
same time, adhesion disassembly and actomyosin activity 
detach and retract the rear of the cell, further propelling the 
cell body forward (Fig. 1).
Directional cell migration is often influenced by the 
two-dimensional and three-dimensional organization of the 
ECM. Recently, there have been advances in our understand-
ing of cell migration. Specifically, around the establishment 
of polarity, the dynamic regulation of actin and microtubule 
polymerization, and the management of spatial and tempo-
ral signal transduction. We aim to address the key steps, 
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important signalling pathways and critical regulators of aor-
tic VSMC migration.
Aortic mechanically properties 
and compliance
The medial layer of the aortic wall contains elastic and non-
elastic extracellular matrix components (Wagenseil and 
Mecham 2009). Elastin provides the majority of the elastic-
ity, whereas non-elastic collagen-I provides tensile strength 
to the medial layer (Wagenseil and Mecham 2009). This 
elasticity is essential for the aorta to respond to changes 
in blood pressure; as blood pulse moves along the vessel, 
the aortic wall expands and recoils behind the blood pulse 
returning the aorta to its original shape (Raij and Gonzalez-
Ochoa 2011). This phenomenon is known as aortic com-
pliance and this is essential for cardiovascular health (Raij 
and Gonzalez-Ochoa 2011). The rigidity of the aortic wall 
determines how compliant the vessel is; if the wall is too 
rigid then the blood pulse will not be sufficient to expand the 
aorta, too soft, then the wall expands excessively resulting in 
wall rupture (Karimi and Milewicz 2016; Cecelja and Chow-
ienczyk 2012). Decreased aortic compliance is observed 
in multiple cardiovascular diseases, including hyperten-
sion, atherosclerosis and diabetes mellitus amongst other 
cardiovascular diseases (Cecelja and Chowienczyk 2012). 
Reduced compliance is associated with augmented arterial 
Fig. 1  Stages of VSMC migra-
tion. Blue lines represent actin 
filaments. Black lines represent 
cell–matrix adhesions. Grey line 
represents extracellular matrix
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stiffness (Izzo and Shykoff 2001). In these conditions, the 
high pulse pressure is unable to expand the stiffened arterial 
wall, resulting in a faster pulse velocity that damages the 
microcirculation of vital organs (Cecelja and Chowienczyk 
2012; Izzo and Shykoff 2001). Vascular smooth muscle cells 
are the predominant cell type in the aortic wall and disease 
associated changes in the mechanical landscape result in 
altered VSMC function (Halka et al. 2008; Shi and Chen 
2015). These changes promote VSMC migration and are 
explored further below.
VSMC function and phenotype
Within physiological conditions, VSMCs exist in a quiescent 
contractile state and use actomyosin generated force to regu-
late vascular tone (Brozovich et al. 2016; Galmiche et al. 
2013). Intermediate filaments, microtubules and actin com-
prise the key filamentous components of VSMCs (Ahmed 
and Warren 2018). The contractile machinery of VSMCs 
in particular are composed of thin actin filaments and thick 
myosin filaments, which collectively form the actomyosin 
complex (Ahmed and Warren 2018). As the blood pulse trav-
els through the aorta, VSMCs become stretched, resulting 
in activation of stretch activated ion channels that facilitate 
 Ca2+ entry and initiate VSMC contraction (Halka et al. 2008; 
Berridge 2008). In addition to this mechanically regulated 
VSMC contraction, soluble factors, including angiotensin II, 
bind to receptors and activate release of  Ca2+ from intracel-
lular stores to promote VSMC contraction (Berridge 2008; 
Inagami et al. 1997). A balance between the mechanical and 
soluble regulation of VSMC contraction determines aortic 
compliance and tone, resulting in controlled organ blood 
flow and pressure.
Despite existing in a contractile phenotype within 
a mature vessel, VSMCs retain a high plasticity and can 
dedifferentiate into a synthetic, migratory phenotype 
(Owens 2007; Alexander and Owens 2012). VSMC phe-
notypic switching is triggered in response to changes in the 
mechanical/biochemical signals, which are typically asso-
ciated with development and cardiovascular diseases, such 
as atherosclerosis and hypertension (Alexander and Owens 
2012). Signals that promote VSMC phenotypic switching 
include growth factors, mitogens, inflammatory mediators 
and mechanical stimuli (Alexander and Owens 2012; Owens 
2007). When dedifferentiated, VSMCs migrate from the 
tunica media to the tunica intima, where the cells are unable 
to regulate vascular tone as effectively, but gain the ability to 
proliferate and increase ECM synthesis (Louis and Zahradka 
2010; Yu et al. 2016). Phenotypic switching is associated 
with a variety of changes that increase VSMC migrational 
capacity and these are discussed further below.
Rho GTPases
The Rho-family of small GTPases are comprised of ~ 20 
GTPases and they exist as a subfamily of the Ras super-
family (Hall 1998). They are well known to play a role in 
cell migration through various effectors proteins (Hall and 
Nobes 2000). The Rho GTPase proteins cycle between an 
active (GTP bound) form and an inactive (GDP bound) 
form. They are regulated temporally by the use of gua-
nine nucleotide exchange factors (GEFs), GTPase-activat-
ing proteins (GAPs) and guanine nucleotide dissociation 
inhibitors (GDIs) (Huang et al. 2015; Bellanger et al. 2000; 
Ohta et al. 2006). GAPs inactivate GTPases by promoting 
hydrolysis of GTP into GDP, whereas GEFs prompt the 
exchange of GDP for GTP which triggers the enzymatic 
activity of the GTPase protein (Hall 1998). GDIs anchor 
the inactivated GTPase proteins within the cytoplasm, pre-
venting interaction with the plasma membrane where it 
undergoes GDP/GTP exchange (Ridley 2001). Of these 20 
GTPase proteins, RhoA, Rac1 and Cdc42 have been heav-
ily characterised and are essential for the regulation of cell 
migration (Hall 1998; Hall and Nobes 2000).
The activation of RhoA is facilitated via the Gα12/13 
subunit, which binds to the p115 Rho GEF and stimulates 
exchange of GDP/GTP (Chen et al. 2012; Patel and Kargi-
nov 2014; Siehler 2009). Once active, RhoA can activate 
its downstream targets, including Rho-associated protein 
kinase 1/2 (ROCK1/2) (Wettschureck and Offermanns 
2002). ROCK1/2 are major downstream RhoA effector 
proteins that belong to the AGC family of serine/threonine 
kinases (Wettschureck and Offermanns 2002). ROCK 1 
and ROCK 2 possess a large number of similarities in both 
structure and function. Overall, they share a 65% identity 
in their amino acid sequence and can be seen to modu-
late mutual functions in endothelial, cardiac and smooth 
muscle cells (Hartmann et al. 2015). However, there is 
evidence that there may be isoform-specific roles of these 
kinases (Yoneda et al. 2005; Vega et al. 2011). One exam-
ple was shown in fibroblast cells, where knockdown of 
ROCK 1 caused aberrant adhesion maturation and actin 
organisation (Yoneda et al. 2005). Contrastingly, ROCK2 
specifically regulates the migratory capacity of prostate 
cancer cells (Vega et al. 2011). ROCK1 and ROCK2 also 
display differential regulation of cardiomyocyte function, 
ROCK1 regulates apoptosis whereas ROCK2 promotes 
hypertrophy (Hartmann et al. 2015). Utilisation of more 
selective inhibitors is therefore required to identify further 
isoform specific roles of the ROCK1/2 kinases (Liao et al. 
2007). In VSMCs, ROCK1/2 activation affects cytoskel-
etal remodelling in two ways; it prevents actin depolymeri-
sation, via inhibition of cofilin, and it can increase basal 
levels of phosphorylated myosin light chain, by inhibiting 
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the activity of myosin light chain phosphatase (Amano 
et al. 2010; Liao et al. 2007; Ridley 2001). The regulation 
of cytoskeletal structure and actomyosin generated force 
production by RhoA plays an important role in VSMC 
migration (Ahmed and Warren 2018). Whether ROCK1 
and ROCK2 possess individual functions during VSMC 
migration remains to be fully explored.
Cdc42 and Rac1 also have multiple roles in cell migra-
tion. Cdc42 and Rac1 have been shown to regulate the 
formation of the filopodia and lamellipodia, respectively 
(Nobes and Hall 1995). Cdc42, via myotonic dystrophy-
related Cdc42-binding kinases (MRCK), shares a similar 
mechanism to ROCK and induces increased myosin light 
chain phosphorylation (Vicente-Manzanares et al. 2005). 
In contrast, Lamellipodia formation via Rac1 is facilitated 
through Arp2/3 complex activation and the uncapping of 
actin filaments present at the cell membrane (Ridley 2001). 
In addition, both Cdc42 and Rac1 interact with and activate 
p21 activated kinase (PAK). Once active, PAK can increase 
the stabilisation of the microtubules as well as regulate cell 
polarity of the cell via the activation of the PIX/PAK com-
plex (Vicente-Manzanares et al. 2005).
The GTPases are critical regulators of the migratory 
process and more work is required to delineate cross talk 
between various GTPases and to further understand their 
dynamic regulation during cell migration.
Actin polymerisation
Actin polymerisation is critical for generating membrane 
protrusions at the leading edge during cell migration. Actin 
polymerisation requires nucleation via the formation of a 
stable actin trimer (Firat-Karalar and Welch 2011). This is 
the rate limiting step in the polymerisation process due to 
the instability of actin dimer intermediates (Firat-Karalar 
and Welch 2011). In order to facilitate actin polymerisation 
and overcome this kinetic demand, cells have evolved a wide 
range of actin-nucleating proteins (Firat-Karalar and Welch 
2011). There are primarily two groups of actin polymeri-
sation nucleators involved in cell migration, the formins, 
mDia1 and mDia2, and the Arp2/3 complex (Toure et al. 
2012; Weise-Cross et al. 2015; Ning et al. 2011). mDia1 
and mDia2 bind to the barbed end of actin filaments and 
polymerise actin linearly, to form thin cellular protrusions 
called filopodia (Watanabe and Higashida 2004). mDia1/2 
are multi-domain proteins that function as dimers, utilising 
their formin homology domain 2 (FH2) to bind to globular 
actin monomers in order to nucleate actin (Goh and Ahmed 
2012; Watanabe and Higashida 2004). The protein profilin 
facilitates the polymerisation via interaction with the formin 
homology 1 (FH1) domain of mDia1/2 (Goh and Ahmed 
2012). RhoA and Cdc42 regulate the mDia1 and mDia2, 
respectively (Watanabe and Higashida 2004).
The Arp2/3 complex is comprised of seven proteins, 
two of which are Arp2 and Arp3 (Weaver et  al. 2003). 
It promotes actin polymerisation in a branched fashion, 
extending actin filaments at a 70° angle from the sides of 
pre-existing filaments (Weaver et al. 2003). Independently, 
the Arp2/3 complex is intrinsically inactive, however it is 
activated by class I nucleation promoting factors (NPFs) 
(Firat-Karalar and Welch 2011). NPFs catalyse the reaction 
that forms lamellipodia by creating a new actin filament 
branch (Firat-Karalar and Welch 2011). Examples of such 
NPFs that regulate Arp2/3 complex activity are WAVE/Scar, 
Wiskott–Aldrich Syndrome protein (WASp) and N-WASp 
(Schenck et al. 2004; Zalevsky et al. 2001). The activity 
of these NPFs are primarily regulated by small GTPase 
proteins. WAVE/Scar is a multi-protein complex and the 
nucleation promoting activity is activated by Rac1, via the 
dissociation of the proteins Abi, Nap125 and Sra-1 from the 
complex (Schenck et al. 2004). In addition to this, Cdc42 has 
been shown to regulate both WASp and N-WASp (Vartiainen 
and Machesky 2004).
Cofilin is a key regulator of actin dynamics and is essen-
tial for directional cell migration. Cofilin is an actin filament 
severing protein and cells with low cofilin levels display 
defects in actin depolymerisation (Gerthoffer 2007). How-
ever, cofilin increases the dynamics of actin filament poly-
merisation at the leading edge by generating free barbed ends 
(Gungabissoon and Bamburg 2003; Ichetovkin et al. 2002). 
These free barbed ends promote actin filament branching 
via the Arp2/3 complex (Ichetovkin et al. 2002). The Arp2/3 
nucleated actin branches are 10 times more stable on these 
recently severed free barbed ends than those produced on 
older filaments (Ichetovkin et al. 2002). Therefore, the func-
tional activity of cofilin is essential in lamellipodia forma-
tion and must be tightly regulated. In resting cells, cofilin 
is directly bound to phosphatidylinositol 4,5-bisphosphate 
 (PIP2) at the plasma membrane. Upon stimulation, cofilin is 
dephosphorylated to sever actin filaments and promote actin 
polymerisation (Van Troys et al. 2008). The actin binding 
protein cortactin can associate with cofilin and inhibit cofi-
lin’s severing activity. Tyrosine phosphorylation of cortactin 
was found to promote cofilin dissociation from cortactin, 
activating the cofilin actin severing function (Van Troys 
et al. 2008; Gungabissoon and Bamburg 2003).
Microtubules
Microtubules are also key modulators of VSMC migration. 
Cell polarisation is a prerequisite for directed cell migra-
tion, and microtubules reorient themselves into an array that 
faces towards the leading edge of the cell (Watanabe et al. 
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2005). This is achieved by selective stabilisation of micro-
tubule plus ends and polarity is abolished by microtubule 
inhibitors (Watanabe et al. 2005). Dynamic instability of 
the microtubules is also a requirement for migration and 
fibroblast cell lines whose microtubules were experimen-
tally stabilised showed a decrease in migrational capacity 
(Gundersen 2002). Small GTPase activity regulates microtu-
bules dynamics. Cdc42 and Rac1 activate PAK, which phos-
phorylates serine 16 and subsequently inactivates stathmin, 
a protein that is important in microtubule destabilisation 
(Cassimeris 2002; Daub et al. 2001; Wittmann et al. 2004). 
Therefore, Cdc42 and Rac1 signalling increase the stability 
of microtubules during cell migration.
VSMC–ECM adhesions
ECM adhesions are a critical component of the VSMC 
migratory process. During migration, VSMC–ECM adhe-
sions assemble at the leading edge and disassemble at the 
trailing end (Vicente-Manzanares et al. 2005). For filopodial 
and lamellipodia protrusions to be maintained, they need 
to be physically anchored to the surrounding environment 
(Vicente-Manzanares et al. 2005; Ridley et al. 2003). Within 
VSMCs, integrins are the major receptor family that form 
VSMC–ECM attachments (Ross et al. 2013; Bottger et al. 
1989). Integrins belong to the type I family of transmem-
brane glycoproteins and mediate VSMC–ECM interactions 
(Miyamoto et al. 1995). They are composed of three struc-
tural components; a large extracellular domain, a transmem-
brane domain and a short cytoplasmic domain (Miyamoto 
et al. 1995). Their heterodimeric (β and α subunit) isoforms 
allow them to have multiple compositions on the cell surface 
and to bind to various ECM proteins such as fibronectin and 
collagen-I (Seetharaman and Etienne-Manneville 2018). The 
beta integrin subunit links the ECM to the actin cytoskeleton 
(Legate and Fassler 2009; Seetharaman and Etienne-Man-
neville 2018). On the cytoplasmic face, adapter proteins, 
such as vinculin and talin, associate with the VSMC–ECM 
adhesion complex (Ross et al. 2013; Legate and Fassler 
2009). These proteins serve to tether the integrin complex 
to the actin cytoskeleton. This allows for “outside in” sig-
nalling which activates signalling pathways within the cell 
(Wrighton 2013). Those mechanical signals cause the rear-
rangement of the actin cytoskeleton during migration (Ross 
et al. 2013). Studies conducted in rat VSMCs showed integ-
rin to be activated by platelet derived growth factor (PDGF) 
which caused actin filaments to relocalise to the leading edge 
of the lamellipodia (Margolin et al. 2002).
Nascent VSMC–ECM adhesion formation at the lead-
ing edge of the cell requires integrin ligation, integrin clus-
tering, phosphorylation of adhesion proteins and an intact 
actin filament meshwork (Miyamoto et al. 1995). Nascent 
VSMC–ECM adhesions are structurally small and either 
quickly disassemble or mature into much larger adhesions 
via an actomyosin dependent process (Sun et al. 2014). 
VSMC–ECM adhesion organisation is controlled by a wide 
range of kinases, including focal adhesion kinase (FAK) and 
integrin linked kinase (ILK) (Abedi et al. 1995; Jiang et al. 
1996). Focal adhesion kinase is a tyrosine kinase composed 
of an N-terminal 4.1 protein, ezrin, radixin and moesin 
(FERM) domain, a proline-rich region and C-terminal tar-
geting domain (Mitra et al. 2005). It has been implicated in 
the regulation of cell motility (Mitra et al. 2005). Phospho-
rylation of FAK in VSMCs has been observed in both vas-
cular injury or when stimulated with growth factors (Abedi 
et al. 1995; Jiang et al. 1996; Owens et al. 2001). Crys-
tal structure analysis reveals that FAK is maintained in an 
inactive conformation via molecular interaction between the 
FERM domain and the catalytic domain (Lietha et al. 2007). 
FAK functions as a scaffold protein and directly phosphoryl-
ates talin and N-WASP (Wu et al. 2004; Feller et al. 2017). 
Integrin linked kinase (ILK) is a serine-threonine protein 
kinase, with a molecular mass of ~ 50 kDa (Dedhar et al. 
1999). It is an important component of the focal adhesion 
complex and associates with vinculin and FAK (Nikolopou-
los and Turner 2001; Stanchi et al. 2009). It has been shown 
to activate PI3 K and inhibit glycogen synthase kinase-3β 
in vascular development through the modulation of down-
stream targets (Li et al. 2016; Dedhar et al. 1999; Ho and 
Bendeck 2009). However, ILK predominantly serves as a 
scaffold protein rather than a kinase at VSMC–ECM adhe-
sion sites during migration (Qin and Wu 2012; Vaynberg 
et al. 2018). ILK is composed of three subunits; the amino 
N-terminal domain comprised of five ankyrin repeats, cen-
tral PH-like domain and the C-terminal kinase catalytic 
domain (Dedhar et al. 1999). ILK co-localizes and interacts 
with several VSMC–ECM adhesion proteins, and such inter-
actions coordinate actin polymerization and VSMC–ECM 
adhesion stability (Dedhar et al. 1999). It can also regulate 
the activation of Rac1 and Cdc42 by interacting with other 
scaffold proteins, such as α-parvin and paxillin (Stanchi 
et al. 2009; Nikolopoulos and Turner 2001). ILK depleted 
cells showed decreased wound closure due to attenuated 
migrational capacity (Yuan et al. 2011; Li et al. 2016).
VSMC–VSMC adhesions
Intercellular adhesions also play an important role in 
migration of numerous cell types. These adhesions, much 
like VSMC–ECM adhesions, are structures which sense 
and respond to mechanical force (Borghi et al. 2012; Gra-
shoff et al. 2010). Cadherins are the primary component 
of cell–cell adhesions and are comprised of three regions; 
an N-terminal domain, followed by a single transmembrane 
 Journal of Muscle Research and Cell Motility
1 3
domain which leads to a small cytoplasmic tail (Sun et al. 
2014a, b). Homodimeric interactions between the N-termi-
nal regions of cadherin proteins from adjacent cells form 
the core of cell–cell contacts (Sun et al. 2014a, b). Lat-
eral E-cadherin interactions between neighbouring cells 
facilitate collective migration in epithelial cells (Suffoletto 
et al. 2018). Within VSMCs, N-cadherin is the predomi-
nant isoform and has been shown to perform multiple roles. 
N-cadherin is essential for efficient VSMC migration, yet it 
remains unknown whether N-cadherin can facilitate collec-
tive migration of VSMCs (Lyon et al. 2010).
Rear‑end detachment
In addition to the leading edge, VSMC–ECM adhesions 
at the rear must detach in order to allow the cell body to 
propel forward (Ridley et al. 2003; Gerthoffer 2007). This 
is required to prevent cell damage occurring from the ten-
sion of the actomyosin generated force (Gerthoffer 2007; 
Vicente-Manzanares et al. 2005). Several mechanisms regu-
lating VSMC-matrix adhesion detachment have been iden-
tified. These include contractility-promoted release, where 
the non-muscle myosin II contractile force exceeds the 
strength of the VSMC–ECM adhesion (Kirfel et al. 2004). 
 Ca2+ levels also play an important role and activation of 
the phosphatase calcineurin, via a  Ca2+-calmodulin depend-
ent mechanism, also promotes adhesion detachment (Kir-
fel et al. 2004). Other mechanisms include modulating the 
affinity of the integrin for both the ECM ligands as well as 
the different cytosolic adaptors (Kirfel et al. 2004). Calpain 
and matrix metalloproteinase (MMP) activity also promote 
VSMC detachment (Gerthoffer 2007; Paulhe et al. 2001; 
Bendeck et al. 1994). Additionally, microtubules have shown 
to promote VSMC–ECM adhesion disassembly at the rear 
of the cell (Yang et al. 2010). Therefore, directed cell migra-
tion also depends on the dynamic regulation of microtubule 
function alongside actin polymerisation and adhesion turno-
ver. Previous models have shown rear-end detachment plays 
a critical role in the reorientation and direction of the cell 
in migration (Theisen et al. 2012). Changes in migrational 
direction are higher following tail retraction, indicating that 
cell detachment precedes the directional change of the cell 
(Theisen et al. 2012). Conversely, increasing the stability of 
adhesions at the cell rear increased migrational directional 
persistence (Theisen et al. 2012).
Recently, a new mode of rapid cellular migration has been 
identified that involves rear end detachment to propel the cell 
over large distances (Wang et al. 2019). This mode is com-
prised of a two steps: (1) matrix stretch and (2) matrix recoil 
(Wang et al. 2019). Actomyosin activity first pulls ECM 
fibres to increase elastic strain energy (Wang et al. 2019). 
When this force exceeds the strength of the rear cell–ECM 
adhesions can withstand, it results in rapid matrix recoil and 
sudden cell movement via release of the strain energy (Wang 
et al. 2019). In addition, it was found that cell rear detach-
ment can cause the formation of migration tracks as previ-
ous cell types, including fibroblasts and sarcoma cells, leave 
behind a trail of cell material which contains integrin micro 
aggregates (Kirfel et al. 2004; Rigort et al. 2004). This intro-
duces a further method of rear cell detachment that could 
promote more efficient cell migration (Kirfel et al. 2004; 
Rigort et al. 2004). It is an intriguing possibility that retrac-
tion may facilitate rapid VSMC migration in 3D environ-
ments and deposit membrane fragments to promote directed 
migration. Whether VSMCs utilise rear end detachment to 
enhance their migrational capacity remains unknown and 
more research is required to examine the importance of 
retraction in VSMC migration.
ECM composition
The ECM is comprised of various structural glycopro-
teins such as collagen-I, elastin, fibronectin and vitronec-
tin (Diez 2007). In the healthy aortic wall, collagen-I and 
elastin are the key structural ECM proteins that determine 
the aortic compliance (Shirwany and Zou 2010). The ECM 
is remodelled during vascular ageing and disease, result-
ing in collagen-I accumulation and elastin degradation 
(Shirwany and Zou 2010). Vascular ECM remodelling 
is further exaggerated when VSMCs dedifferentiate into 
their synthetic phenotype (Diez 2007). This phenotype is 
associated with increased synthesis of ECM components, 
including collagen-I, and enhanced matrix metalloprotein-
ase (MMPs) enzymes (Okada et al. 1992; Bendeck et al. 
1994). MMPs are classified into six major subclasses based 
on their dependency of  Zn2+ binding for proteolytic activ-
ity (Fanjul-Fernandez et al. 2010). They are; collagenases, 
gelatinases, stromelysins, matrilysins, membrane-type (MT) 
and other non-classified MMPs (Fanjul-Fernandez et al. 
2010; Myasoedova et al. 2018). Their activity is regulated 
by three mechanisms which are transcription, secretion and 
activation of the inactive zymogens and proenzymes (Mya-
soedova et al. 2018; Tallant et al. 2010; Galis and Khatri 
2002). The activation of secreted pro-MMPs requires proteo-
lytic removal of the pro-domain, by disrupting the Cys-Zn2+ 
interaction (Tallant et al. 2010). Membrane type MMPS such 
as MT1-MMP are known to activate pro-MMPs. (Mya-
soedova et al. 2018) Upon activation, MMPs degrade the 
elastic extracellular matrix and connective tissue (Myasoe-
dova et al. 2018; Galis and Khatri 2002). In VSMCs, tightly 
controlled partial degradation of the ECM is a crucial step 
to allow cells to reposition during remodelling. However, 
uncontrolled MMP activation can result in damaged ECM 
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that enables unregulated VSMC migration (Belo et al. 2015; 
Galis et al. 2002).
In atherosclerotic lesions, VSMCs display altered gene 
expression as a result of switching to their synthetic phe-
notype (Owens 2007). Analysis has shown that the fibrous 
plaques from these lesions contain a high concentration of 
collagen-I/III (Raines 2000). This uncontrolled increase in 
collagen expression by VSMCs during migration causes the 
thickening of the arterial wall which ultimately results in 
reduced aortic compliance (Cecelja and Chowienczyk 2012). 
Previous research shows that there is heterogeneity in the 
mechanical stiffness of both healthy and diseased tissue 
(Tracqui et al. 2011). This heterogeneity produces stiffness 
gradients that promotes directional movement in VSMCs. 
This type of migration is known as durotaxis (Hartman et al. 
2016; Isenberg et al. 2009). Within atherosclerotic plaques, 
VSMCs are exposed to a wide range of ECM stiffnesses, 
with regions ranging between 5 kPa → 200 kPa (Tracqui 
et al. 2011). The composition of the ECM is also important 
for VSMC durotaxis as fibronectin, an ECM component 
found in high abundance within atherosclerotic lesions, pro-
motes VSMC directed cell migration (Hartman et al. 2016). 
Despite this, only a few studies have investigated how ECM 
composition and ECM stiffness gradients serve as VSMC 
directional cues.
The nuclear lamina and VSMC migration
The nuclear envelope (NE) and nuclear lamina have surpris-
ingly emerged as regulators of cell migration. The NE is 
comprised of a double lipid bilayer that forms a physical bar-
rier between the cytoplasm and nuclear interior (Lammerd-
ing 2011). The nuclear lamina underlies the NE and provides 
structural support to the NE (Gruenbaum et al. 2005). The 
nuclear lamina is a meshwork of filamentous A-type lamins 
(lamins A/C), B-type lamins (lamin B1 and B2) type lamins 
and associated lamin binding proteins (Gruenbaum et al. 
2005). Importantly, the nuclear lamina indirectly associ-
ates with cytoplasmic filamentous intermediate filaments, 
microtubule and actin networks. This is achieved by a NE 
spanning complex known as the LInker of Nucleoskeleton 
and Cytoskeleton (LINC) complex (Crisp et al. 2006). The 
LINC complex consists of giant nesprin proteins that are 
tethered to the outer nuclear membrane by a Klarsicht, Anc-
1, Syne-1 Homology (KASH) domain (Zhang et al. 2001, 
2007). The cytoplasmic facing nesprin proteins make mul-
tiple connections to the filamentous networks with multiple 
spectrin repeats and an N-terminal paired calponin homol-
ogy domain, which directly binds filamentous actin (Zhang 
et al. 2001; Jayo et al. 2016; Kutscheidt et al. 2014). LINC 
complex stability is maintained via interactions between the 
nesprin KASH domain and the SUN-domain of the SUN 
family of proteins in the perinuclear space (Crisp et al. 2006; 
Haque et al. 2006; Sosa et al. 2012). The SUN proteins span 
the inner nuclear membrane and interact with lamins A/C in 
the nucleoplasm (Haque et al. 2010). Cytoskeletal derived 
biophysical signals are transmitted across the LINC com-
plex and regulate association of the nuclear lamina with the 
NE and activated nuclear signalling (Arsenovic et al. 2016; 
Guilluy et al. 2014; Wu et al. 2014). The LINC complex also 
transmits inside out signals from the nuclear lamina to the 
cytoskeleton as disruption of the LINC complex or nuclear 
lamina triggers cytoskeletal reorganisation, altered GTPase 
signalling and impaired cell migration (Schwartz et al. 2017; 
Chambliss et al. 2013). However, the nature of these inside 
out signals remains unknown.
The A-type lamins are encoded by the LMNA gene (Rusi-
nol and Sinensky 2006). Lamin C is directly generated from 
the LMNA gene (Rusinol and Sinensky 2006). In contrast, 
lamin A is generated from the prelamin A precursor protein 
that requires several post translational modification steps to 
generate mature lamin A (Rusinol and Sinensky 2006). Prel-
amin A is farnesylated and is inserted into the INM (Rusinol 
and Sinensky 2006). To release mature lamin A from the 
INM, prelamin A must be processed by the metalloprotein-
ase FACE1, which cleaves the C-terminal 15 amino acids of 
prelamin A, that include the farnesyl modification, to yield 
soluble mature lamin A (Rusinol and Sinensky 2006; Corri-
gan et al. 2005). Improper prelamin A processing is observed 
in Hutchinson–Gilford progeria syndrome (HGPS) acceler-
ated ageing and in normal VSMC ageing. HGPS patients 
display accelerated ageing and possess a mutation that 
removes the FACE1 cleavage site in prelamin A (Rusinol 
and Sinensky 2006). This results in defective lamin A pro-
cessing and prelamin A accumulation at the INM. VSMCs 
are severely affected in HGPS, suggesting that VSMCs are 
extremely sensitive to changes in lamin A processing (Rag-
nauth et al. 2010; Olive et al. 2010; McClintock et al. 2006). 
Prelamin A accumulation is also observed in normal VSMC 
ageing and is driven by loss of FACE1 expression (Ragnauth 
et al. 2010). In both situations, prelamin A accumulation is 
proposed to interfere with mature lamin A function. HGPS-
derived fibroblast cells exhibit cytoskeletal reorganisation, 
cell–ECM adhesion remodelling and reduced migrational 
capacity (Chang et al. 2019; Booth-Gauthier et al. 2013). 
Importantly, prelamin A accumulation or lamin A deple-
tion in VSMCs showed similar changes in cytoskeletal and 
cell–ECM adhesion organisation as HGPS-derived fibro-
blasts (Porter et al. 2016). In VSMCs, the nuclear lamina 
influences migrational directional persistence via regulation 
of Rac1 (Porter et al. 2016). Although the mechanism of 
this regulation remains unknown, it is likely that the LINC 
complex is involved. Further experimentation is required to 
better understand the role of the nuclear lamina and LINC 
complex in VSMC migration within physiological and path-
ological environments.
 Journal of Muscle Research and Cell Motility
1 3
DNA damage and 3D migration
Much of our knowledge discussed above has been gener-
ated on 2D surfaces. In vivo, cells must navigate complex 
3D environments. The ECM is a porous network and as 
VSMCs move, they secrete MMPs to expand these pores, 
so VSMC migration is unhindered (Wolf et al. 2013). How-
ever, vascular calcification, where blood vessel walls calcify 
and become similar to bone, is observed in many vascu-
lar diseases, including atherosclerosis and diabetes (Liu 
and Shanahan 2011). In these conditions, VSMCs cannot 
degrade the calcified ECM to expand the pore size. How 
VSMCs migrate in these conditions remains completely 
unknown. Other cell types undergo a process known as 
constricted migration under conditions where they are una-
ble to increase pore size (Wolf et al. 2013). The cytoplasm 
is not limited by ECM pore size, however, the nucleus is 
the largest and stiffest cellular organelle (Wolf et al. 2013) 
(Fig. 2). For cells to migrate though pores of limited size, 
cells use actomyosin generated force to squeeze the nucleus 
though (Davidson et al. 2014) (Fig. 2). This process results 
in nuclear deformation and places considerable pressure on 
the NE that ultimately results in NE damage and rupture 
(Denais et al. 2016; Xia et al. 2018). The nuclear envelope 
is a protective barrier separating the nuclear content from 
the cytoplasm. This allows compartmentalisation of crucial 
molecular components which facilitate processes such as 
DNA replication and RNA synthesis. NE rupture results 
in loss of this barrier function and induces DNA damage, 
which is predicted to promote genomic mutations that accel-
erate cancer metastasis (Xia et al. 2018; Irianto et al. 2017; 
Denais et al. 2016). DNA damage accumulation is known 
to accelerate prelamin A accumulation and VSMC ageing 
(Ragnauth et al. 2010). Aged VSMCs adopt a secretory 
phenotype that further accelerates blood vessel calcification 
(Liu et al. 2013). Therefore, VSMCs undergoing confined 
migration may promote the secretory phenotype and fur-
ther accelerate vascular ageing (Liu et al. 2013; Ragnauth 
et al. 2010). Whether VSMCs undergo constricted migration 
within the calcified vessel wall remains unknown. However, 
given the importance of DNA damage in driving VSMC 
dysfunction and vessel wall deterioration, this remains a key 
unanswered question.
Future directions
Much research exists into the role of soluble factors and 
biochemical signalling in VSMC migration. However, we 
lack an understanding of two key areas: (1) how biophysical 
signalling and intercellular coupling between the cytoskel-
eton and nucleus contributes to VSMC migration; and (2) 
the role of insoluble factors, including matrix stiffness and 
porosity. Biophysical signalling and insoluble cues are 
known to change during ageing and vascular disease. There-
fore, unravelling the mechanistic role of these changes will 
potentially identify novel therapeutic pathways to manipu-
late VSMC migration in ageing and vascular disease.
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